Clinical Trial Update: Screening of Biomarkers and Related Mechanisms for RIX

View source ↗

Summary

An ongoing clinical trial at Zhejiang University is screening biomarkers and mechanisms related to radiotherapy-induced xerostomia (RIX).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Xerostomia

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Xerostomia Due to Radiotherapy (Disorder) | Status: RECRUITING